Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Homeobox protein NKX6-3 is a member of the NK6 subfamily of homeobox transcription factors characterized by a homeodomain that binds DNA to regulate gene transcription. It is expressed in the developing central nervous system and gastrointestinal tract, where it plays a role in the patterning and differentiation of neural and epithelial cells. NKX6-3 is implicated in the negative regulation of gastric mucosal atrophy and inflammatory signaling, which links it to roles in cancer and inflammatory conditions of the gut. However, it is primarily considered a developmental transcription factor rather than a classic therapeutic target such as a receptor or enzyme.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Homeobox protein NKX6-3 (NKX6-3).